Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-YearGlobeNewsWire • 02/12/26
Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal YearGlobeNewsWire • 02/05/26
Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. MarketGlobeNewsWire • 01/28/26
Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 01/02/26
Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 12/31/25
Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase MarginsGlobeNewsWire • 12/31/25
Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health MonitoringGlobeNewsWire • 12/18/25
Intelligent Bio Solutions to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 2-3, 2025Newsfile Corp • 11/20/25
Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue GrowthGlobeNewsWire • 11/12/25
Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-YearGlobeNewsWire • 11/04/25
Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480GlobeNewsWire • 10/30/25
Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service ProviderGlobeNewsWire • 10/23/25
Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and ClearanceGlobeNewsWire • 09/26/25
Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening SystemGlobeNewsWire • 09/17/25
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in JulyGlobeNewsWire • 08/19/25
Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational EfficienciesGlobeNewsWire • 08/15/25
Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025GlobeNewsWire • 08/12/25
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational MomentumGlobeNewsWire • 08/07/25
Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market LaunchGlobeNewsWire • 08/06/25
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport OperatorGlobeNewsWire • 07/30/25
Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross ProceedsGlobeNewsWire • 07/25/25
Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform ResilienceGlobeNewsWire • 07/23/25